Literature DB >> 29491486

Low nocturnal diastolic ocular perfusion pressure as a risk factor for NTG progression: a 5-year prospective study.

Pushpa Raman1, Nurull Bahya Suliman1, Mimiwati Zahari1, Michael Kook2, Norlina Ramli3.   

Abstract

OBJECTIVE: To assess the relationship between baseline intraocular pressure (IOP), blood pressure (BP) and ocular perfusion pressure (OPP), and the 5-year visual field progression in normal-tension glaucoma (NTG) patients.
DESIGN: Prospective, longitudinal study.
METHODS: Sixty-five NTG patients who were followed up for 5 years are included in this study. All the enrolled patients underwent baseline 24-h IOP and BP monitoring via 2-hourly measurements in their habitual position and were followed up for over 5 years with reliable VF tests. Modified Anderson criteria were used to assess VF progression. Univariable and multivariable analyses using Cox's proportional hazards model were used to identify the systemic and clinical risk factors that predict progression. Kaplan-Meier survival analyses were used to compare the time elapsed to confirmed VF progression in the presence or absence of each potential risk factor.
RESULTS: At 5-year follow-up, 35.4% of the enrolled patients demonstrated visual field progression. There were statistically significant differences in the mean diastolic blood pressure (p < 0.05) and diastolic OPP (p < 0.05) between the progressing and the non-progressing group. There was no association between IOP parameters and NTG progression. Multivariable analysis identified low nocturnal DOPP at baseline as a significant predictive risk factor for glaucomatous visual field progression at 5 years. An mmHg decrease in nocturnal DOPP increases the hazard of progression by 1.4 times. Patients with DOPP < 35 mmHg have 2.3-fold higher probability of progressing compared to the patients with DOPP > 43.7 mmHg (log rank = 0.018).
CONCLUSION: Diastolic parameters of BP and OPP were significantly lower in the NTG patients who progressed after 5 years. Low nocturnal DOPP is an independent predictor of glaucomatous visual field progression in NTG patients.

Entities:  

Mesh:

Year:  2018        PMID: 29491486      PMCID: PMC6043484          DOI: 10.1038/s41433-018-0057-8

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  22 in total

1.  Low diastolic blood pressure is associated with the progression of normal-tension glaucoma.

Authors:  Yoshihiko Okumura; Kenya Yuki; Kazuo Tsubota
Journal:  Ophthalmologica       Date:  2012-02-25       Impact factor: 3.250

2.  Racial variations in the prevalence of primary open-angle glaucoma. The Baltimore Eye Survey.

Authors:  J M Tielsch; A Sommer; J Katz; R M Royall; H A Quigley; J Javitt
Journal:  JAMA       Date:  1991-07-17       Impact factor: 56.272

3.  Circadian fluctuation of mean ocular perfusion pressure is a consistent risk factor for normal-tension glaucoma.

Authors:  Jaewan Choi; Kyung Hoon Kim; Jinho Jeong; Hyun-Soo Cho; Chang Hwan Lee; Michael S Kook
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-01       Impact factor: 4.799

4.  A randomized trial of brimonidine versus timolol in preserving visual function: results from the Low-Pressure Glaucoma Treatment Study.

Authors:  Theodore Krupin; Jeffrey M Liebmann; David S Greenfield; Robert Ritch; Stuart Gardiner
Journal:  Am J Ophthalmol       Date:  2011-01-22       Impact factor: 5.258

5.  Low nocturnal ocular perfusion pressure as a risk factor for normal tension glaucoma.

Authors:  N Ramli; B S Nurull; Noran N Hairi; Z Mimiwati
Journal:  Prev Med       Date:  2013-01-23       Impact factor: 4.018

Review 6.  Collaborative normal tension glaucoma study.

Authors:  Douglas R Anderson
Journal:  Curr Opin Ophthalmol       Date:  2003-04       Impact factor: 3.761

7.  The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Collaborative Normal-Tension Glaucoma Study Group.

Authors: 
Journal:  Am J Ophthalmol       Date:  1998-10       Impact factor: 5.258

8.  Risk factors for visual field progression in the low-pressure glaucoma treatment study.

Authors:  Carlos Gustavo De Moraes; Jeffrey M Liebmann; David S Greenfield; Stuart K Gardiner; Robert Ritch; Theodore Krupin
Journal:  Am J Ophthalmol       Date:  2012-07-25       Impact factor: 5.258

Review 9.  Population-based glaucoma prevalence studies in Asians.

Authors:  Hyun-Kyung Cho; Changwon Kee
Journal:  Surv Ophthalmol       Date:  2014-05-13       Impact factor: 6.048

10.  Normal-tension glaucoma (Low-tension glaucoma).

Authors:  Douglas R Anderson
Journal:  Indian J Ophthalmol       Date:  2011-01       Impact factor: 1.848

View more
  6 in total

1.  Blood pressure control and glaucoma risk in postmenopausal women: an analysis from the Women's Health Initiative.

Authors:  Bernhard Haring; Kathleen Hovey; Mike LaMonte; Chris Andrews; Nazmus Saquib; JoAnn E Manson; Daichi Shimbo; Robert Ritch; Carlos Gustavo De Moraes; Sylvia Wassertheil-Smoller
Journal:  Menopause       Date:  2022-05-01       Impact factor: 2.953

Review 2.  [Vasculat treatment concepts in glaucoma patients].

Authors:  Karin R Pillunat; Lutz E Pillunat
Journal:  Ophthalmologe       Date:  2021-05       Impact factor: 1.059

3.  In glaucoma patients, low blood pressure is accompanied by vascular dysregulation.

Authors:  Tatjana Binggeli; Andreas Schoetzau; Katarzyna Konieczka
Journal:  EPMA J       Date:  2018-11-12       Impact factor: 6.543

4.  Inter-eye correlation analysis of 24-h IOPs and glaucoma progression.

Authors:  Mohamad Dakroub; Raoul Verma-Fuehring; Vaia Agorastou; Julian Schön; Jost Hillenkamp; Frank Puppe; Nils A Loewen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-05-02       Impact factor: 3.535

5.  HIOP-Reader: Automated Data Extraction for the Analysis of Manually Recorded Nycthemeral IOPs and Glaucoma Progression.

Authors:  Vaia Agorastou; Julian Schön; Raoul Verma-Fuehring; Mohamad Dakroub; Jost Hillenkamp; Frank Puppe; Nils A Loewen
Journal:  Transl Vis Sci Technol       Date:  2022-06-01       Impact factor: 3.048

6.  Latest Developments in Normal-Pressure Glaucoma: Diagnosis, Epidemiology, Genetics, Etiology, Causes and Mechanisms to Management.

Authors:  Jacky W Y Lee; Poemen P Chan; XiuJuan Zhang; Li Jia Chen; Jost B Jonas
Journal:  Asia Pac J Ophthalmol (Phila)       Date:  2019 Nov-Dec
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.